U.S. markets closed

Veeva Systems Inc. (VEEV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
320.56-4.69 (-1.44%)
At close: 4:00PM EDT
320.30 -0.26 (-0.08%)
After hours: 07:56PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close325.25
Bid314.78 x 1300
Ask321.29 x 900
Day's Range320.30 - 327.78
52 Week Range235.74 - 343.96
Avg. Volume742,995
Market Cap49.18B
Beta (5Y Monthly)0.79
PE Ratio (TTM)122.35
EPS (TTM)2.62
Earnings DateNov 29, 2021 - Dec 03, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est342.05
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-8% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VEEV

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Veeva Systems Inc.
    Analyst Report: Veeva Systems Inc.Veeva is a leading supplier of software solutions for the life sciences industry. The company’s best-of-breed offering addresses operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise and cloud-based platform to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning, or ERP, systems that have limited flexibility. As the vertical leader, Veeva innovates, increases wallet share at existing customers, and expands into other industries with similar regulations, protocols, and procedures, such as consumer goods, chemicals, and cosmetics.
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
  • PR Newswire

    Survey Finds Industry Taking Action to Address Challenges from Rapid Move to Decentralized Trials Amid COVID-19

    Sponsors and contract research organizations (CROs) are accelerating digital transformation to advance toward patient-centric, paperless, and decentralized trials, according to the Digital Clinical Trials Survey Report conducted by Veeva Systems (NYSE: VEEV). The new global research shows life sciences companies are taking decisive action to improve operational challenges stemming from the rapid adoption of decentralized technologies during COVID-19, evolving to a study model that expands beyond

  • Zacks

    Syneos Health's (SYNH) New Pact Boosts Tech-Driven Solutions

    Syneos Health's (SYNH) recent acquisition boosts the company's ability to deliver strategic insights and technology-enabled solutions that address the customers' most complex data challenges.

  • PR Newswire

    Veeva Vault CDMS Delivers Agility and Speed for Oncology Trials

    Veeva Systems (NYSE: VEEV) today announced that the number of biotechs using Veeva Vault CDMS to run faster, more effective oncology trials more than doubled over the last year. Vault CDMS, a modern cloud application suite designed to manage clinical data for today's study builds, delivers the agility and efficiency needed to handle the demands of highly complex studies.